According to research report the gel documentation systems market
size is expected to reach USD 304 million by 2023 from USD 258 million
in 2018, at a CAGR of 3.3%. The major factors driving the market are
growing global incidence of infectious diseases and genetic disorders
and increase in funding for research & development in genomics,
proteomics, and electrophoresis techniques.
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17162887
Prominent players in the gel documentation systems market include GE
Healthcare (US), Bio-Rad Laboratories, Inc. (US), Thermo Fisher
Scientific (US), LI-COR Biosciences (US), Endress+Hauser Management AG
(Switzerland), Vilber Lourmat (France), Scientific Digital Imaging plc
(UK), Bio-Techne (US), Cleaver Scientific (US), and Azure Biosystems
(US).
The key strategies followed by most companies in the gel documentation
systems market are product launches & approvals, expansions,
agreements & collaborations, and acquisitions to achieve growth in
the global gel documentation systems market. Product launches accounted
for the largest share of the overall growth strategies adopted from 2015
to 2018.
Bio-Rad Laboratories, Inc. was the leading player in the gel
documentation systems market. Strong brand recognition and extensive
product portfolio in the gel documentation systems market are the
company’s key strength. To maintain a leading position in the market,
the company focuses on research & development activities to develop
and introduce new products in the market. The company invested 11.6%,
10%, and 9.6% of its total revenue in research & development in
2017, 2016, and 2015, respectively. The company launches new products
regularly to maintain its dominant presence and promotes its products
through various webinars. It recently launched ChemiDoc MP Imaging
system. It has a presence in over 30 countries among which, the US is
the largest market. The company registered 37% of its revenue from the
US in 2017.
GE Healthcare was the second-largest player in the gel documentation
systems market. The company offers a wide range of gel documentation
systems for protein and nucleic acid quantification. GE’s
well-established distribution channels in mature markets, such as North
America and Europe, help it to maintain its leading position in the life
sciences industry. The company is also focusing on organic growth
strategies; for example, it recently entered into an agreement with the
Swedish government to open a test centre for innovation in life
sciences.
Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=17162887
Thermo Fisher Scientific was the third-largest player in the global gel
documentation market. The company’s leading position in the market can
be attributed to its focus on product innovation. It focuses on
strengthening its R&D capabilities, core competencies, and meeting
customer and market demands. This has helped Thermo Fisher to introduce
innovative products in the market. In the last two years, the company
launched iBright CL1000 and iBright FL1000 imaging systems. Product
launches strengthen the company’s product portfolio, brand recognition,
and help the company to maintain its position in the market. The company
has a strong presence in more than 150 countries in Europe, North
America, South America, Asia Pacific, and Africa.
